Localization of an hTERT repressor region on human chromosome 3p21.3 using chromosome engineering

Genome Integrity

Volumn 1, Issue , 2010, Pages

  Abe, Satoshi ^a,b   Tanaka, Hiromi ^b   Notsu, Tomomi ^a   Horike, Shin Ichi ^c   Fujisaki, Chikako ^a   Qi, Dong Lai ^a   Ohhira, Takahito ^a   Gilley, David ^b   Oshimura, Mitsuo ^a   Kugoh, Hiroyuki ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; RETROVIRUS VECTOR; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL DIVISION; CHICKEN; CHROMOSOME 3P; ENZYME ACTIVITY; GENE EXPRESSION; GENE LOCATION; GENE REPRESSION; GENETIC ENGINEERING; GENETIC REGULATION; HTERT GENE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPRESSOR GENE;

EID: 77955430241     PISSN: None     EISSN: 20419414     Source Type: Journal    
DOI: 10.1186/2041-9414-1-6     Document Type: Article

References (39)

1. Blackburn EH. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett 2005, 579:859-862. 10.1016/j.febslet.2004.11.036, 15680963.
2. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997, 33:787-791. 10.1016/S0959-8049(97)00062-2, 9282118.
3. Belgiovine C, Chiodi I, Mondello C. Telomerase: cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex. Cytogenet Genome Res 2008, 122:255-262. 10.1159/000167811, 19188694.
4. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T, Ishikawa F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998, 18:65-68. 10.1038/ng0198-65, 9425903.
5. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997, 90:785-795. 10.1016/S0092-8674(00)80538-3, 9288757.
6. Horikawa I, Barrett JC. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 2003, 24:1167-1176. 10.1093/carcin/bgg085, 12807729.
7. Flores I, Benetti R, Blasco MA. Telomerase regulation and stem cell behaviour. Curr Opin Cell Biol 2006, 18:254-260. 10.1016/j.ceb.2006.03.003, 16617011.
8. Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, Tahara E, Shay JW, Barrett JC, Oshimura M. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 1995, 86:899-904.
9. Tanaka H, Shimizu M, Horikawa I, Kugoh H, Yokota J, Barrett JC, Oshimura M. Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region. Genes Chromosomes Cancer 1998, 23:123-133. 10.1002/(SICI)1098-2264(199810)23:2<123::AID-GCC5>3.0.CO;2-4, 9739015.
10. Horikawa I, Oshimura M, Barrett JC. Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinog 1998, 22:65-72. 10.1002/(SICI)1098-2744(199806)22:2<65::AID-MC1>3.0.CO;2-J, 9655250.
11. National Center for Biotechnology Information. , http://www.ncbi.nlm.nih.gov/
12. Whitehead Institute/MIT. , http://www-genome.wi.mit.edu/
13. UCSC Genome Bioinformatics. , http://genome.ucsc.edu/
14. Horikawa I, Cable PL, Mazur SJ, Appella E, Afshari CA, Barrett JC. Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression. Mol Biol Cell 2002, 13:2585-2597. 10.1091/mbc.E01-11-0107, 117927, 12181331.
15. Ducrest AL, Amacker M, Mathieu YD, Cuthbert AP, Trott DA, Newbold RF, Nabholz M, Lingner J. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res 2001, 61:7594-7602.
16. Szutorisz H, Lingner J, Cuthbert AP, Trott DA, Newbold RF, Nabholz M. A chromosome 3-encoded repressor of the human telomerase reverse transcriptase (hTERT) gene controls the state of hTERT chromatin. Cancer Res 2003, 63:689-695.
17. Dowdy SF, Scanlon DJ, Fasching CL, Casey G, Stanbridge EJ. Irradiation microcell-mediated chromosome transfer (XMMCT): The generation of specific Chromosomal arm deletions. Genes Chromosomes Cancer 1990, 2:318-327. 10.1002/gcc.2870020410, 2268580.
18. Imreh S, Klein G, Zabarovsky ER. Search for unknown tumor-antagonizing genes. Genes Chromosomes Cancer 2003, 38:307-321. 10.1002/gcc.10271, 14566849.
19. Buerstedde JM, Takeda S. Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell 1991, 67:179-188. 10.1016/0092-8674(91)90581-I, 1913816.
20. Dieken ES, Epner EM, Fiering S, Fournier RE, Groudine M. Efficient modification of human chromosomal alleles using recombination-proficient chicken/human microcell hybrids. Nat Genet 1996, 12:174-182. 10.1038/ng0296-174, 8563756.
21. Koi M, Lamb PW, Filatov L, Feinberg AP, Barrett JC. Construction of chicken x human microcell hybrids for human gene targeting. Cytogenet Cell Genet 1997, 76:72-76. 10.1159/000134519, 9154132.
22. Kuroiwa Y, Shinohara T, Notsu T, Tomizuka K, Yoshida H, Takeda S, Oshimura M, Ishida I. Efficient modification of a human chromosome by telomere-directed truncation in high homologous recombination-proficient chicken DT40 cells. Nucleic Acids Res 1998, 26:3447-3448. 10.1093/nar/26.14.3447, 147703, 9649633.
23. Meaburn KJ, Parris CN, Bridger JM. The manipulation of chromosomes by mankind: the uses of microcell-mediated chromosome transfer. Chromosoma 2005, 114:263-274. 10.1007/s00412-005-0014-8, 16133353.
24. Nishimoto A, Miura N, Horikawa I, Kugoh H, Murakami Y, Hirohashi S, Kawasaki H, Gazdar A, Shay J, Barrett JC, Oshimura M. Functional evidence for a telomerase repressor gene on human chromosome 10p15.1. Oncogene 2001, 20:828-835. 10.1038/sj.onc.1204165, 11314017.
25. Oshimura M, Barrett JC. Multiple pathways to cellular senescence: role of telomerase repressors. Eur J Cancer 1997, 33:710-715. 10.1016/S0959-8049(97)00090-7, 9282109.
26. Tanaka H, Horikawa I, Barrett JC, Oshimura M. Evidence for inactivation of distinct telomerase repressor genes in different types of human cancers. Int J Cancer 2005, 115:653-657. 10.1002/ijc.20879, 15688423.
27. Ji L, Minna JD, Roth JA. 3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncol 2005, 1:79-92. 10.1517/14796694.1.1.79, 16555978.
28. Szutorisz H, Lingner J, Cuthbert AP, Trott DA, Newbold RF, Nabholz M. A chromosome 3-encoded repressor of the human telomerase reverse transcriptase (hTERT) gene controls the state of hTERT chromatin. Cancer Res 2003, 63:689-695.
29. Yang ZQ, Yoshida MA, Fukuda Y, Kurihara N, Nakamura Y, Inazawa J. Molecular cytogenetic analysis of 17 renal cancer cell lines: increased copy number at 5q31-33 in cell lines from nonpapillary carcinomas. Jpn J Cancer Res 2000, 91:156-163.
30. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009, 60:167-179. 10.1146/annurev.med.59.053006.104707, 19630570.
31. Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, Kato K, Komatsu H, Ikeda K, Wakabayashi G, Masuda T. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci 2008, 99:280-286. 10.1111/j.1349-7006.2007.00666.x, 18201269.
32. Hoshiya H, Kazuki Y, Abe S, Takiguchi M, Kajitani N, Watanabe Y, Yoshino T, Shirayoshi Y, Higaki K, Messina G, Cossu G, Oshimura M. A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene. Mol Ther 2009, 17:309-317. 10.1038/mt.2008.253, 2835068, 19034264.
33. Katoh M, Ayabe F, Norikane S, Okada T, Masumoto H, Horike S, Shirayoshi Y, Oshimura M. Construction of a novel human artificial chromosome vector for gene delivery. Biochem Biophys Res Commun 2004, 321:280-290. 10.1016/j.bbrc.2004.06.145, 15358173.
34. Kazuki Y, Hoshiya H, Kai Y, Abe S, Takiguchi M, Osaki M, Kawazoe S, Katoh M, Kanatsu-Shinohara M, Inoue K, Kajitani N, Yoshino T, Shirayoshi Y, Ogura A, Shinohara T, Barrett JC, Oshimura M. Correction of a genetic defect in multipotent germline stem cells using a human artificial chromosome. Gene Ther 2008, 15:617-624. 10.1038/sj.gt.3303091, 18305578.
35. Kouprina N, Larionov V. TAR cloning: insights into gene function, long-range haplotypes and genome structure and evolution. Nat Rev Genet 2006, 7:805-812. 10.1038/nrg1943, 16983376.
36. Nihei N, Kouprina N, Larionov V, Oshima J, Martin GM, Ichikawa T, Barrett JC. Functional evidence for a metastasis suppressor gene for rat prostate cancer within a 60-kilobase region on human chromosome 8p21-p12. Cancer Res 2002, 62:367-370.
37. Kugoh HM, Hashiba H, Shimizu M, Oshimura M. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080. Oncogene 1990, 5:1637-1644.
38. Wong JM, Kusdra L, Collins K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol 2002, 4:731-736. 10.1038/ncb846, 12198499.
39. Tomizuka K, Yoshida H, Uejima H, Kugoh H, Sato K, Ohguma A, Hayasaka M, Hanaoka K, Oshimura M, Ishida I. Functional expression and germline transmission of a human chromosome fragment in chimaeric mice. Nat Genet 1997, 16:133-143. 10.1038/ng0697-133, 9171824.